secwatch.observer — SEC 8-K summary
======================================

Issuer:     VIEMED HEALTHCARE, INC. (VMD)
CIK:        0001729149
Form:       8-K
Filed at:   2025-08-06T23:59:59+00:00
Accession:  0001729149-25-000118
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Viemed Q2 net revenue $63.1M (record, +14.7% YoY); diluted EPS $0.08 vs $0.04
-----------------------------------------------------------------------------

- Net revenues for Q2 2025 hit $63.1M, a record high, up 14.7% from $55.0M in Q2 2024.
- Net income attributable to Viemed $3.2M ($0.08 diluted EPS) vs $1.5M ($0.04) YoY, +115.1%.
- Adjusted EBITDA $14.3M, up 11.5% over the prior year quarter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729149/000172914925000118/0001729149-25-000118-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729149/000172914925000118/vmd-20250806.htm
  HTML page:      https://secwatch.observer/filing/0001729149-25-000118

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer